Skip to main content

Icosavax, Inc.

ICVXDelisted Feb 20, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001786255

Icosavax, Inc. was delisted on Feb 20, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 93 institutions reported holding it in 13F filings for Q4 2023, worth $663.0M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Icosavax, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ICVX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders73165−7
Shares32.1M1.36M32.5M+1.77M (+5.8%)
Value$101.5M$4.30M$258.3M+$161.1M (+165.8%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Icosavax, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ICVX in Q4 2022
InstitutionSharesValue% of portfolio
Invesco Ltd.469,403$3.73M0.00%
HighTower Advisors, LLC59,076$469.0K0.00%
Walleye Capital LLC49,138$390.2K0.01%
Marquette Asset Management, LLC29,823$236.8K0.07%
Ergoteles LLC29,709$235.9K0.01%
XTX Topco Ltd14,272$113.3K0.02%
MetLife Investment Management12,698$100.8K0.00%
Quantamental Technologies LLC11,596$92.1K0.04%
Spire Wealth Management10,631$84.0K0.00%
Metropolitan Life Insurance Co1,497$11.9K0.00%
Cutler Group LP1,012$8.00K0.00%

Sold out (18)

Institutions that held Icosavax, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (1)

Institutions that held Icosavax, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ICVX in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
NanoDimension, Inc.1,361,658$4.30M